|Articles|November 8, 2016
myClin Selected for LLS Clinical Trial
The Leukemia & Lymphoma Society (LLS) has selected myClin for its Acute Myeloid Leukemia (AML) clinical trial.
Advertisement
The Leukemia & Lymphoma Society (LLS) has selected myClin for its Acute Myeloid Leukemia (AML) clinical trial. The myClin Clinical Trial Knowledge Platform will assist clinical study entities by streamlining communication to share study documents.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
4
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
5